NOD2 Down-Regulates Colonic Inflammation by IRF4-Mediated Inhibition of K63-Linked Polyubiquitination of RICK and TRAF6

[1]  A. Ma,et al.  A20: linking a complex regulator of ubiquitylation to immunity and human disease , 2012, Nature Reviews Immunology.

[2]  Yuekang Xu,et al.  Targeting IRF4 in autoimmune diseases. , 2012, Autoimmunity reviews.

[3]  M. Kudo,et al.  Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis. , 2012, Immunity.

[4]  J. Hugot,et al.  Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. , 2012, Cell host & microbe.

[5]  R. Jessberger,et al.  Dual regulation of IRF4 function in T and B cells is required for the coordination of T–B cell interactions and the prevention of autoimmunity , 2012, The Journal of experimental medicine.

[6]  N. Rose,et al.  Faculty Opinions recommendation of Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. , 2012 .

[7]  D. Philpott,et al.  Nod‐like receptors in intestinal homeostasis, inflammation, and cancer , 2011, Journal of leukocyte biology.

[8]  Tomohiro Watanabe,et al.  NOD2, an Intracellular Innate Immune Sensor Involved in Host Defense and Crohn's Disease , 2011, Mucosal Immunology.

[9]  Ricardo G. Correa,et al.  Non-apoptotic role of BID in inflammation and innate immunity , 2011, Nature.

[10]  M. Neurath,et al.  IRF4 regulates IL‐17A promoter activity and controls ROR&ggr;t‐dependent Th17 colitis in vivo , 2011, Inflammatory bowel diseases.

[11]  W. Strober,et al.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. , 2011, Gastroenterology.

[12]  C. Abraham,et al.  Secretory mediators regulate Nod2-induced tolerance in human macrophages. , 2011, Gastroenterology.

[13]  G. Bhagat,et al.  Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. , 2010, The Journal of clinical investigation.

[14]  T. Mak,et al.  This information is current as and Prevents Acute Renal Failure Inflammationwhich Suppresses Postischemic Cells , Regulatory Factor 4 in Renal Dendritic Ischemia Reperfusion Induces IFN , 2010 .

[15]  Lieping Chen,et al.  NOD2 Ligation Subverts IFN-α Production by Liver Plasmacytoid Dendritic Cells and Inhibits Their T Cell Allostimulatory Activity via B7-H1 Up-Regulation1 , 2009, The Journal of Immunology.

[16]  P. Scacheri,et al.  ITCH K63-Ubiquitinates the NOD2 Binding Protein, RIP2, to Influence Inflammatory Signaling Pathways , 2009, Current Biology.

[17]  M. Bertrand,et al.  Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. , 2009, Immunity.

[18]  M. Kopf,et al.  The Kinase Activity of Rip2 Determines Its Stability and Consequently Nod1- and Nod2-mediated Immune Responses* , 2009, The Journal of Biological Chemistry.

[19]  M. Neurath,et al.  The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. , 2008, The Journal of clinical investigation.

[20]  Judy H. Cho,et al.  The genetics and immunopathogenesis of inflammatory bowel disease , 2008, Nature Reviews Immunology.

[21]  L. Joosten,et al.  Crohn’s disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross‐tolerance to intestinal stimuli , 2008, Immunology.

[22]  G. Núñez,et al.  The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. , 2008, Immunity.

[23]  Tomohiro Watanabe,et al.  Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. , 2008, The Journal of clinical investigation.

[24]  P. Lucas,et al.  A critical role of RICK/RIP2 polyubiquitination in Nod‐induced NF‐κB activation , 2008 .

[25]  P. Lucas,et al.  A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. , 2008, The EMBO journal.

[26]  M. Kelliher,et al.  NOD2 Pathway Activation by MDP or Mycobacterium tuberculosis Infection Involves the Stable Polyubiquitination of Rip2* , 2007, Journal of Biological Chemistry.

[27]  Judy H. Cho,et al.  Chronic stimulation of Nod2 mediates tolerance to bacterial products , 2007, Proceedings of the National Academy of Sciences.

[28]  H. Clevers,et al.  The Paneth Cell α-Defensin Deficiency of Ileal Crohn’s Disease Is Linked to Wnt/Tcf-41 , 2007, The Journal of Immunology.

[29]  L. Cantley,et al.  Coordinated Regulation of Toll-Like Receptor and NOD2 Signaling by K63-Linked Polyubiquitin Chains , 2007, Molecular and Cellular Biology.

[30]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[31]  H. Clevers,et al.  The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. , 2007, Journal of immunology.

[32]  Chafen Lu,et al.  Identification of a regulatory autophosphorylation site in the serine-threonine kinase RIP2. , 2006, Cellular signalling.

[33]  L. Komuves,et al.  Non-viral delivery of nuclear factor-κB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis , 2006, Gut.

[34]  Tomohiro Watanabe,et al.  Signalling pathways and molecular interactions of NOD1 and NOD2 , 2006, Nature Reviews Immunology.

[35]  Setsuya Aiba,et al.  Synergistic Effect of Nod1 and Nod2 Agonists with Toll-Like Receptor Agonists on Human Dendritic Cells To Generate Interleukin-12 and T Helper Type 1 Cells , 2005, Infection and Immunity.

[36]  K. Honda,et al.  Negative regulation of Toll-like-receptor signaling by IRF-4. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Matsuyama,et al.  Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Preiß,et al.  Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides , 2005 .

[39]  Zhijian J. Chen.  Ubiquitin signalling in the NF-κB pathway , 2005, Nature Cell Biology.

[40]  M. Chamaillard,et al.  NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. , 2005, Annual review of biochemistry.

[41]  Clive M. Onnie,et al.  Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease , 2005, The Lancet.

[42]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[43]  Zhijian J. Chen.  Ubiquitin signalling in the NF-kappaB pathway. , 2005, Nature cell biology.

[44]  L. Cantley,et al.  The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.

[45]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[46]  Yasodha Natkunam,et al.  Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry , 2001, Modern Pathology.